Cell-free detection of methylated breast tumor
AssigneesQueen's University at Kingston, Institut Curie, Institut National De La Sante Et De La Recherche Medicale (Inserm)
InventorChristopher R. MUELLER
Life of this patent
Estimating the term…
Loading patent…
AssigneesQueen's University at Kingston, Institut Curie, Institut National De La Sante Et De La Recherche Medicale (Inserm)
InventorChristopher R. MUELLER
Estimating the term…
Provided herein is a method for detecting a tumour that can be applied to cell-free samples, to cell-free detect circulating tumour DNA. The method utilizes detection of adjacent methylation signals within a single sequencing read as the basic positive tumour signal, thereby decreasing false positives. The method comprises extracting DNA from a cell-free sample obtained from a subject, bisulphite converting the DNA, amplifying regions methylated in cancer (CpG islands, CpG shores, and/or CpG shelves), generating sequencing reads, and detecting tumour signals. To increase sensitivity, biased primers designed based on bisulphite converted methylated sequences can be used. Target methylated regions can be selected from a pre-validated set according to the specific aim of the test. Absolute number, proportion, and/or distribution of tumour signals may be used for tumour detection or classification. The method is also useful in, predicting, prognosticating, and/or monitoring response to treatment, tumour load, relapse, cancer development, or risk.
A method of detecting the presence of breast cancer, comprising:
Dependencies are inferred from the claim text.